4 completed. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
Follow AIDSVAX B-E: new trials by email Literature Review of AIDSVAX B-E trials Research Report on AIDSVAX B-E
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Effect of Late Boost on HIV-uninfected Vaccines From EV06 Trial DNA-HIV-PT123 & AIDSVAX B/E - HIV/AIDS | Phase 1 | Completed | EuroVacc Foundation | 49 | 2017-03-15 | 2019-02-07 |
| Safety and Immunogenicity Study of a DNA Vaccine Combined With Protein Vaccine Against HIV/AIDS DNA, AIDSVAX B/E - HIV/AIDS | Phase 1 | Completed | EuroVacc Foundation | 72 | 2014-09-01 | 2016-01-22 |
| Evaluating the Safety and Immune Response to Different Combinations of the DNA-HIV-PT123 and AIDSVAX® B/E Vaccines in Healthy, HIV-Uninfected Adults AIDSVAX B/E Vaccine, DNA-HIV-PT123 Vaccine, Placebo for DNA-HIV-PT123 - HIV Infections | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 104 | 2014-07-01 | 2021-10-15 |
| Safety of and Immune Response to Vaccination With 2 Experimental HIV Vaccines in Healthy Adults ALVAC-HIV, AIDSVAX B/E, Placebo for ALVAC-HIV - HIV Infection | Phase 1 | Completed | HIV Vaccine Trials Network | 202 | 2013-06-18 | 2019-06-21 |
Acquired Immunodeficiency Syndrome (2) · HIV Infections (2) · Trematode Infections (1)
EuroVacc Foundation (2) · HIV Vaccine Trials Network (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
Uganda (2) · South Africa (1) · United States (1)
Pontiano Kaleebu (2) · Glenda Gray, MD (1) · Michael Keefer (1)
PMID 40190112, PMID 25401780, PMID 31566579, PMID 31999736, PMID 32577626, PMID 34843602, PMID 36762930